Skip to main content
. 2023 Feb 6;26:11137. doi: 10.3389/jpps.2023.11137

FIGURE 5.

FIGURE 5

Plasma concentration of S-verapamil in patients with active rheumatoid arthritis (RA) and healthy controls (A). Despite increased plasma concentration, the pharmacological effect of verapamil was reduced in RA patients compared to healthy controls (B). From (37).